What antidepressant is preferred for an adult patient who needs increased appetite and improved sleep, assuming no contraindications such as recent MAOI use, uncontrolled hypertension, or severe hepatic impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antidepressant for Appetite and Sleep

Mirtazapine is the preferred antidepressant for patients requiring both appetite stimulation and improved sleep, with typical dosing of 15-30 mg at bedtime. 1, 2

Why Mirtazapine is the Optimal Choice

Mirtazapine uniquely addresses both target symptoms through its dual mechanism: it blocks presynaptic alpha-2 adrenergic receptors and postsynaptic serotonin receptors (5-HT2 and 5-HT3), producing both sedation and appetite stimulation. 3, 4

Sleep Benefits

  • Mirtazapine consistently improves all objective sleep parameters including sleep efficiency, total sleep time, and sleep quality across multiple controlled trials. 5
  • The sedating effects are dose-dependent, with lower doses (7.5-15 mg) being MORE sedating due to greater histaminergic effects at lower concentrations. 1
  • Mirtazapine demonstrated faster onset of sleep improvement compared to SSRIs like fluoxetine and paroxetine (significant improvement by weeks 1-4). 4
  • The American Academy of Sleep Medicine recognizes sedating antidepressants including mirtazapine as appropriate for insomnia associated with depression. 2

Appetite and Weight Benefits

  • Increased appetite and weight gain are the most consistently reported effects with mirtazapine compared to other antidepressants. 4
  • This side effect profile becomes therapeutic when appetite stimulation is desired. 2
  • The National Comprehensive Cancer Network specifically recommends mirtazapine for patients with depression, anorexia, AND sleep disturbances. 1

Practical Dosing Algorithm

Start with 15 mg at bedtime for most adult patients. 3

  • If sedation is the primary goal with minimal antidepressant effect needed: consider 7.5 mg (more sedating due to histamine effects). 1
  • If inadequate response after 1-2 weeks: increase to 30 mg at bedtime. 6
  • For elderly patients: start at 7.5 mg to minimize excessive sedation. 1

Important Clinical Caveats

Weight gain is inevitable and substantial - this is the desired effect for appetite stimulation but becomes problematic if not clinically indicated. Seven of 11 patients in one study gained weight on mirtazapine. 7

Agranulocytosis risk exists (approximately 1 in 1,000) though it is rare and usually reversible with discontinuation. 8

Sedation-related side effects are common - somnolence is the most frequently reported adverse effect, which may impair daytime functioning if dosed incorrectly. 8, 3

Alternative Considerations

If mirtazapine is not tolerated or contraindicated:

  • Trazodone is the second-line sedating antidepressant with minimal anticholinergic effects but does NOT stimulate appetite. 2
  • Doxepin at low doses (3-6 mg) improves sleep but lacks appetite-stimulating properties. 2
  • Amitriptyline provides both sedation and appetite stimulation but has significantly more anticholinergic side effects (dry mouth, constipation, urinary retention). 2

What NOT to Use

SSRIs and SNRIs are inappropriate for this indication - they commonly cause insomnia and nausea rather than sedation and appetite stimulation. 9

Evidence specifically shows antidepressants as a class are LESS effective than benzodiazepines and benzodiazepine receptor agonists for primary insomnia when depression is not present. 9 However, when depression coexists with insomnia and poor appetite, mirtazapine addresses all three conditions simultaneously. 2

References

Guideline

Mirtazapine and Melatonin Combination Therapy for Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Non-Narcotic Medications for Insomnia Associated with Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mirtazapine, an antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Research

The effects of mirtazapine on sleep in patients with major depressive disorder.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2012

Guideline

Mirtazapine Use in Adolescents for Sleep Issues

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Mirtazapine: a newer antidepressant.

American family physician, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.